About GardianT3

GardianT3 COVID-19 SARS-CoV-2 Rapid Antigen Test is a saliva based lateral flow immunoassay self test intended to detect SARS-CoV-2 nucelocapsic antigens present in human saliva samples in vitro. This rapid antigen test is intended to be used in symptomatic individuals meeting the case definition for COVID-19 within the first 7 days of symptom onset, and to test individuals suspected of COVID-19 due to contact with a confirmed COVID-19 case or probable cases, and at-risk health workers. 

 

Positive results are indicative of the presence of SARS-CoV-2. Positive results do not rule out a bacterial infection or co-infection with other viruses. Negative results do not rule out SARS-CoV-2 infection. Individuals who test negative and continue to experience symptoms should seek follow up care from their local state or territory COVID-19 testing centre.